Streltima 90 mg, Injektionslösung in einer Fertigspritze

7680705250028 CH-70525 Injektionslösung

Associated product:

STRELTIMA sol inj 90 mg/ml ser pré 1 ml

No image available

Article details

Package size
1
Selling units
1
Measure
Spritze(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
ustekinumabum
90.0 MG Substance Wirkstoff (Principe actif)
saccharum
- Substance HNIDK
histidinum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Janssen-Cilag AG

6300 Zug

Authorization information

Swissmedic authorization number
70525
Drug name
Streltima, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
L04AC05
Authorization status
Z
Authorization category
Category C
Dispensing category
B
First authorization
30/09/2025
Authorization expiration date
30/09/2026
IT Number
07.15.0.
Domain
Human medicine
Field of application
Plaque-Psoriasis ab 6 Jahren, Psoriasis-Arthritis, Morbus Crohn, Ulcerative Colitis

Package details

Description (FR)
STRELTIMA sol inj 90 mg/ml ser pré 1 ml
Description (DE)
STRELTIMA Inj Lös 90 mg/ml Fertspr 1 ml
Market launch
24/12/2026
Narcotic (BTM)
No

Other package sizes (1)

STRELTIMA sol inj 45 mg/0.5ml ser prê 0.5 ml
1 SPRI
GTIN: 7680705250011
View
Buy us a coffee Explore the data